Univariate Cox regression analyses initially indicated that primary tumor site, T staging, clinical stage, lymph node metastasis and serum CCL18 level were significantly associated with the overall survival in patients with LSCC (All P < 0.05; Table 2). The gene discussed is CCL18; the disease is metastatic malignant neoplasm in the lymph nodes.